LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 11.56 | 771.67 | 1299 | 1280 | 1.0143 | 1.0394 | MN20160304_L01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 11.56 | 771.67 | 1134 | 1280 | 0.8855 | 0.6934 | MN20160304_L01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 13.78 | 771.67 | 1446 | 1459 | 0.9906 | 0.9795 | MN20160304_L01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 13.78 | 771.67 | 1217 | 1459 | 0.8337 | 0.6411 | MN20160304_L01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 16.00 | 771.67 | 1497 | 1585 | 0.9442 | 0.8924 | MN20160304_L01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 16.00 | 771.67 | 1274 | 1585 | 0.8035 | 0.6203 | MN20160304_L01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 18.22 | 771.67 | 1558 | 1741 | 0.8947 | 0.8192 | MN20160304_L01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 18.22 | 771.67 | 1346 | 1741 | 0.7730 | 0.6061 | MN20160304_L01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 20.44 | 771.67 | 1617 | 1910 | 0.8462 | 0.7603 | MN20160304_L01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 20.44 | 771.67 | 1413 | 1910 | 0.7395 | 0.5879 | MN20160304_L01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 22.66 | 771.67 | 1651 | 2141 | 0.7710 | 0.6762 | MN20160304_L01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 22.66 | 771.67 | 1486 | 2141 | 0.6939 | 0.5605 | MN20160304_L01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 24.89 | 771.67 | 1779 | 2397 | 0.7420 | 0.6664 | MN20160304_L01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 24.89 | 771.67 | 1574 | 2397 | 0.6565 | 0.5462 | MN20160304_L01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 27.11 | 771.67 | 1901 | 2675 | 0.7106 | 0.6531 | MN20160304_L01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 27.11 | 771.67 | 1671 | 2675 | 0.6246 | 0.5385 | MN20160304_L01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 29.33 | 771.67 | 2012 | 2939 | 0.6845 | 0.6433 | MN20160304_L01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 29.33 | 771.67 | 1782 | 2939 | 0.6063 | 0.5431 | MN20160304_L01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 31.55 | 771.67 | 2161 | 3196 | 0.6760 | 0.6523 | MN20160304_L01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 31.55 | 771.67 | 1895 | 3196 | 0.5928 | 0.5498 | MN20160304_L01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 33.78 | 771.67 | 2312 | 3499 | 0.6606 | 0.6538 | MN20160304_L01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 33.78 | 771.67 | 2043 | 3499 | 0.5838 | 0.5626 | MN20160304_L01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 36.00 | 771.67 | 2450 | 3884 | 0.6307 | 0.6413 | MN20160304_L01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 36.00 | 771.67 | 2172 | 3884 | 0.5591 | 0.5586 | MN20160304_L01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 38.22 | 771.67 | 2612 | 4299 | 0.6075 | 0.6356 | MN20160304_L01 | E22 |